Skip to main navigation Skip to main content

On demand webinar

Thrombosis and Thrombocytopenia Syndrome (TTS) and the use of the COVID-19 AstraZeneca vaccine in younger populations: an update for General Practitioners Members login for free access About RACGP online events

Details

Type: On-demand
Recorded: 26 Jul 2021

Contact

For more information:
Email: NSW&ACT Events
Call: 02 9886 4707

Price

RACGP Members: FREE
Non-Members: FREE

Watch now

Thrombosis and Thrombocytopenia Syndrome (TTS) and the use of the COVID-19 AstraZeneca vaccine in younger populations: an update for General Practitioners

On-demand recorded 26 Jul 2021

Following on from A GPs guide to Thrombosis and Thrombocytopenia Syndrome (TTS), this webinar will provide an update on the latest Australian and international statistics relevant to TTS in younger populations, and summarise the current knowledge regarding the protection afforded by the AstraZeneca vaccine against the delta variant of COVID-19.

Learning outcomes

  1. Review the incidence, morbidity and mortality data relevant to TTS in our younger populations
  2. Discuss the impact of treatment on patient outcomes following a diagnosis of TTS
  3. Understand the impact of the delta variant on our younger populations
  4. Discuss efficacy of AstraZeneca vaccination against the delta variant
This event attracts 2 CPD points

This event attracts 2 CPD points

Facilitators

Dr Charlotte Hespe
Chair, RACGP NSW&ACT

Dr Ai-Vee Chua
General Practitioner, Dubbo Family Doctors

In her role as a clinician, Dr Ai-Vee Chua enjoys all aspects of general practice, and has particular interests in general medicine, children's health, and women's health. She is a strong proponent of preventive health, and is committed to a patient-centered approach to healthcare.

Presenters

Dr Vivien Chen

Dr Danny Hsu
Senior Staff Specialist (Haematology)

Advertising

© 2021 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807